BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 18462078)

  • 1. Serological response to human endogenous retrovirus K in melanoma patients correlates with survival probability.
    Hahn S; Ugurel S; Hanschmann KM; Strobel H; Tondera C; Schadendorf D; Löwer J; Löwer R
    AIDS Res Hum Retroviruses; 2008 May; 24(5):717-23. PubMed ID: 18462078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer progression correlates with increased humoral immune response to a human endogenous retrovirus GAG protein.
    Reis BS; Jungbluth AA; Frosina D; Holz M; Ritter E; Nakayama E; Ishida T; Obata Y; Carver B; Scher H; Scardino PT; Slovin S; Subudhi SK; Reuter VE; Savage C; Allison JP; Melamed J; Jäger E; Ritter G; Old LJ; Gnjatic S
    Clin Cancer Res; 2013 Nov; 19(22):6112-25. PubMed ID: 24081977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibodies to stuctural proteins of endogenous retrovirus of the HERV-K/HTDV family as markers of human germ cell tumors].
    Seniuta NB; Kleĭman AM; Triakin AA; Karseladze AI; Shelepova VM; Tiuliandin SA; Gurtsevich VE
    Vopr Virusol; 2006; 51(3):17-21. PubMed ID: 16826751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical use of p-proteasome in discriminating metastatic melanoma patients: comparative study with LDH, MIA and S100B protein.
    Henry L; Fabre C; Guiraud I; Bastide S; Fabbro-Peray P; Martinez J; Lavabre-Bertrand T; Meunier L; Stoebner PE
    Int J Cancer; 2013 Jul; 133(1):142-8. PubMed ID: 23238767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of human endogenous retrovirus K in melanomas and melanoma cell lines.
    Büscher K; Trefzer U; Hofmann M; Sterry W; Kurth R; Denner J
    Cancer Res; 2005 May; 65(10):4172-80. PubMed ID: 15899808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.
    Paschen A; Sucker A; Hill B; Moll I; Zapatka M; Nguyen XD; Sim GC; Gutmann I; Hassel J; Becker JC; Steinle A; Schadendorf D; Ugurel S
    Clin Cancer Res; 2009 Aug; 15(16):5208-15. PubMed ID: 19671853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma.
    Egberts F; Kotthoff EM; Gerdes S; Egberts JH; Weichenthal M; Hauschild A
    Eur J Cancer; 2012 Mar; 48(5):695-702. PubMed ID: 21917447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of T lymphocytes specific for human endogenous retrovirus K (HERV-K) in patients with seminoma.
    Rakoff-Nahoum S; Kuebler PJ; Heymann JJ; E Sheehy M; Ortiz GM; S Ogg G; Barbour JD; Lenz J; Steinfeld AD; Nixon DF
    AIDS Res Hum Retroviruses; 2006 Jan; 22(1):52-6. PubMed ID: 16438646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-100B protein and melanoma inhibitory activity protein in uveal melanoma screening. A comparison with liver function tests.
    Missotten GS; Korse CM; van Dehn C; Linders TC; Keunen JE; Jager MJ; Bonfrer JM
    Tumour Biol; 2007; 28(2):63-9. PubMed ID: 17264538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a HERV-K env surface peptide highly recognized in Rheumatoid Arthritis (RA) patients: a cross-sectional case-control study.
    Mameli G; Erre GL; Caggiu E; Mura S; Cossu D; Bo M; Cadoni ML; Piras A; Mundula N; Colombo E; Buscetta G; Passiu G; Sechi LA
    Clin Exp Immunol; 2017 Jul; 189(1):127-131. PubMed ID: 28324619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a melanoma marker derived from melanoma-associated endogenous retroviruses.
    Humer J; Waltenberger A; Grassauer A; Kurz M; Valencak J; Rapberger R; Hahn S; Löwer R; Wolff K; Bergmann M; Muster T; Mayer B; Pehamberger H
    Cancer Res; 2006 Feb; 66(3):1658-63. PubMed ID: 16452225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic effect of American Joint Committee on Cancer staging and genetic status in patients with choroidal and ciliary body melanoma.
    Bagger M; Andersen MT; Andersen KK; Heegaard S; Andersen MK; Kiilgaard JF
    Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):438-44. PubMed ID: 25537201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum markers to detect metastatic uveal melanoma.
    Barak V; Frenkel S; Kalickman I; Maniotis AJ; Folberg R; Pe'er J
    Anticancer Res; 2007; 27(4A):1897-900. PubMed ID: 17649791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100-Beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma.
    Deichmann M; Benner A; Bock M; Jäckel A; Uhl K; Waldmann V; Näher H
    J Clin Oncol; 1999 Jun; 17(6):1891-6. PubMed ID: 10561230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HERV-K(HML-2) GAG/ENV antibodies as indicator for therapy effect in patients with germ cell tumors.
    Kleiman A; Senyuta N; Tryakin A; Sauter M; Karseladze A; Tjulandin S; Gurtsevitch V; Mueller-Lantzsch N
    Int J Cancer; 2004 Jun; 110(3):459-61. PubMed ID: 15095315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of S100 protein and MIA protein as serum marker for malignant melanoma.
    Djukanovic D; Hofmann U; Sucker A; Rittgen W; Schadendorf D
    Anticancer Res; 2000; 20(3B):2203-7. PubMed ID: 10928178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival analysis in metastatic melanoma: serum S100B is an independent prognostic marker and superior to LDH.
    Egberts F; Pollex A; Egberts JH; Kaehler KC; Weichenthal M; Hauschild A
    Onkologie; 2008 Jul; 31(7):380-4. PubMed ID: 18596385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of human endogenous retrovirus-K expression in melanomas by CpG methylation.
    Stengel S; Fiebig U; Kurth R; Denner J
    Genes Chromosomes Cancer; 2010 May; 49(5):401-11. PubMed ID: 20095041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of S-100-beta serum concentration in patients with uveal melanoma.
    Missotten GS; Tang NE; Korse CM; Hurks HM; de Wolff-Rouendaal D; Keunen JE; Jager MJ; Bonfrer JM
    Arch Ophthalmol; 2003 Aug; 121(8):1117-9. PubMed ID: 12912688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum S-100b protein as a prognostic marker in malignant cutaneous melanoma.
    Mårtenson ED; Hansson LO; Nilsson B; von Schoultz E; Månsson Brahme E; Ringborg U; Hansson J
    J Clin Oncol; 2001 Feb; 19(3):824-31. PubMed ID: 11157036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.